Evidence map›Paper›PMID 27366053›Full record

ArticlePatient preference and adherence2016

The association between comorbidities and the quality of life among colorectal cancer survivors in the People's Republic of China.

Ji-Wei Wang, Li Sun, Ning Ding, Jiang Li, Xiao-Huan Gong, Xue-Fen Chen, Dong-Hui Yu, Zheng-Nian Luo, Zheng-Ping Yuan, Jin-Ming Yu

Open access · goldAbstract read
In one paragraph

Article in Patient preference and adherence, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Observational
  2. Article
  3. The relationship of chronic disease conditions to mental and physical health among cancer survivors.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
  4. Article
  5. Article
  6. Quality of life among chronic myeloid leukemia patients in the second-line treatment with nilotinib and influential factors.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2022
    Article
  7. Article
  8. Article
  9. Examination of individual and multiple comorbid conditions and health-related quality of life in older cancer survivors.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Ji-Wei WangSchool of Public Health and Key Laboratory of Public Health Safety, Fudan University, Shanghai, People's Republic of China.
Li SunSchool of Public Health and Key Laboratory of Public Health Safety, Fudan University, Shanghai, People's Republic of China; Changzhou Center for Disease Control and Prevention, Changzhou, Jiangsu Province, People's Republic of China.
Ning DingCentre for Research and Action in Public Health, The University of Canberra, Canberra, ACT, Australia.
Jiang LiJonathan and Karin Fielding School of Public Health, University of California, Los Angeles, CA, USA.
Xiao-Huan GongSchool of Public Health and Key Laboratory of Public Health Safety, Fudan University, Shanghai, People's Republic of China.
Xue-Fen ChenSchool of Public Health and Key Laboratory of Public Health Safety, Fudan University, Shanghai, People's Republic of China.
Dong-Hui YuCollege of Clinical Medicine, Anhui Medical University, Hefei, Anhui Province, People's Republic of China.
Zheng-Nian LuoShanghai Health Education Association, Shanghai, People's Republic of China.
Zheng-Ping YuanShanghai Cancer Rehabilitation Club, Shanghai, People's Republic of China.
Jin-Ming YuSchool of Public Health and Key Laboratory of Public Health Safety, Fudan University, Shanghai, People's Republic of China.
Fudan University · CNFielding Graduate University · USAnhui Medical University · CNUniversity of Canberra · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCancer survivors with certain comorbidities had lower quality of life (QOL). This study was performed to investigate the prevalence of comorbidities and the association between comorbidities and the QOL among Chinese colorectal cancer survivors (CCS).

methodsA cross-sectional study was conducted among 1,398 CCS between April and July 2013 in Shanghai, People's Republic of China. All the participants were asked to complete a simplified Chinese version of the European Organization for Research and Treatment quality of life version 3 questionnaire and questions on sociodemographic characteristics and comorbidities. In order to mitigate the bias caused by confounding factors, multiple linear regression models were employed to calculate the adjusted means of QOL scores.

resultsThe proportion of participants without any comorbidity was only 20.2%. The CCS with comorbidities except hypertension scored significantly lower on the European Organization for Research and Treatment quality of life version 3 questionnaire global health and functioning scales and Functional Assessment of Cancer Therapy-General scales but higher on the European Organization for Research and Treatment quality of life version 3 questionnaire symptom scores, indicating that they had poorer QOL, particularly for cardiovascular, respiratory, digestive, and musculoskeletal diseases.

conclusionThere exists a significant association between comorbidities and QOL among Chinese CCS, and participants with comorbidities generally reported lower QOL scores. These findings suggested comprehensive care for CCS.

Indexed as

cancer carecolorectal cancer survivorscomorbiditiesquality of life

Identifiers

PMID27366053
PMCPMC4913535
OpenAlexW2421357130

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.